510(k) Report

510(k) · Cleared

Cleared

Neurovascular Access System Family

K240746510(k) TraditionalCleared Nov 20, 2024246-day reviewClass II21 CFR 870.1250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Q'Apel Medical, Inc. · QJP Catheter, Percutaneous, Neurovasculature

Cleared on Nov 20, 2024 as substantially equivalent to K212838 (Penumbra, Inc., 2022) and 1 other predicate after a 246-day review. Its family tree reaches back 9 generations to 2001.

Decided
Nov 20, 2024
Review
246 days
Class
Class II
Product code
QJP
Recalls
None
Predicates
2

Its longest line of descent runs back 9 generations to K010954 (2001). 12 ancestors in all, the oldest K010853 (2001). No later device cites it as a predicate yet.

  1. Root · 9 generations backK010954 Concentric Balloon Guide Catheter, Model 90031Concentric Medical, Inc. · 2001 · Recalled
  2. 5 generations between
  3. 3 generations backK181000 SelectFlex 072 Neurovascular Access SystemQ'Apel · 2018
  4. 2 generations backK191664 SelectFlex 072 Neurovascular Access SystemQ'Apel Medical · 2019
  5. 1 generation backK211893 SelectFlex Neurovascular Access System FamilyQ'Apel Medical, Inc. · 2021
  6. This deviceK240746 Neurovascular Access System FamilyQ'Apel Medical, Inc. · 2024
Show all 9 generations
  1. Root · 9 generations backK010954 Concentric Balloon Guide Catheter, Model 90031Concentric Medical, Inc. · 2001 · Recalled
  2. 8 generations backK021899 Concentric Balloon Guide Catheter, Model 90072Concentric Medical, Inc. · 2002 · Recalled
  3. 7 generations backK053491 Penumbra Balloon Guide Catheter, Model 7.5FPenumbra, Inc. · 2006
  4. 6 generations backK070970 Neuron Support Catheter System, Model 5F/6FPenumbra, Inc. · 2007 · Recalled
  5. 5 generations backK082290 Neuron Delivery Catheter 070Penumbra, Inc. · 2008 · Recalled
  6. 4 generations backK142321 Benchmark Intracranial Access SystemPenumbra, Inc. · 2015
  7. 3 generations backK181000 SelectFlex 072 Neurovascular Access SystemQ'Apel · 2018
  8. 2 generations backK191664 SelectFlex 072 Neurovascular Access SystemQ'Apel Medical · 2019
  9. 1 generation backK211893 SelectFlex Neurovascular Access System FamilyQ'Apel Medical, Inc. · 2021
  10. This deviceK240746 Neurovascular Access System FamilyQ'Apel Medical, Inc. · 2024
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−9K010954Concentric Balloon Guide Catheter, Model 90031Concentric Medical, Inc.20011
−8K021899Concentric Balloon Guide Catheter, Model 90072Concentric Medical, Inc.20021
−7K053491Penumbra Balloon Guide Catheter, Model 7.5FPenumbra, Inc.2006—
−6K070970Neuron Support Catheter System, Model 5F/6FPenumbra, Inc.20071
−5K082290Neuron Delivery Catheter 070Penumbra, Inc.20081
−4K142321Benchmark Intracranial Access SystemPenumbra, Inc.2015—
−3K181000SelectFlex 072 Neurovascular Access SystemQ'Apel2018—
−2K191664SelectFlex 072 Neurovascular Access SystemQ'Apel Medical2019—
−1K211893SelectFlex Neurovascular Access System FamilyQ'Apel Medical, Inc.2021—
0 (this device)K240746Neurovascular Access System FamilyQ'Apel Medical, Inc.2024—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110
200810
202210
FIG. 1 — Lineage of K240746, 2001–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QJP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QJP device

  1. #1 K212838 Benchmark Intracranial Access Systemscore 16.9 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K212838Benchmark Intracranial Access System
Summary page 5
…Codes: QJP, DQY Regulatory Class: II III. PREDICATES Primary predicate • Benchmark Intracranial Access System, K212838 Secondary predicate • SelectFlex Neurovascular Access System Family, K211893 IV. DEVICE DESCRIPTION…
Penumbra, Inc.2022—
*K211893SelectFlex Neurovascular Access System Family
Summary page 5
…Primary predicate • Benchmark Intracranial Access System, K212838 Secondary predicate • SelectFlex Neurovascular Access System Family, K211893 IV. DEVICE DESCRIPTION The subject Neurovascular Access System Family consists of sterile, single-use catheters and…
Q'Apel Medical, Inc.2021—

Also cleared against K212838: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 5 companies; a new generation was cleared every 1.9 years on median.
  • 6 of the 12 ancestors have a recall of any class.
  • 3 other devices also cite its predicate K212838.

How does its category compare?

All QJP devices

QJP Catheter, Percutaneous, Neurovasculature: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · QJP

22so far in 2026, the most since 2007

2020: 92021: 122022: 142023: 142024: 182025: 142026 (partial year): 22
2007high 22 (2026) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QJP

116in 2025

2020: 72 days median2021: 139 days median2022: 206 days median2023: 184 days median2024: 188 days median2025: 116 days median2026 (partial year): 141 days median
2007high 206 (2022) · low 72 (2020)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QJP

1in 2024

2024: 1
2007high 1 (2024) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · QJP

688in 2025

2020: 162021: 292022: 302023: 752024: 1302025: 688
2007high 688 (2025) · low 0 (2007)2025

MAUDE reports naming product code QJP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
2020972016
202112139029
202214206030
202314184075
2024181881130
2025141160688
2026221410—

What is it indicated for?

The Neurovascular Access System Family is indicated for the introduction of interventional devices into the peripheral and neuro vasculature. It is not intended for use in coronary arteries.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K240746: Neurovascular Access System Family.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K240746

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026